Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Mogasale VV"'
Autor:
Mogasale VV; Department of Infectious Disease Epidemiology and Dynamics, London School of Hygiene & Tropical Medicine, London, UK.; School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan., Sinha A; Indian Institute of Public Health-Gandhinagar, India., John J; Department of Community Health, Christian Medical College, Vellore, India., Hasan Farooqui H; College of Medicine, Qatar University, Doha, Qatar., Ray A; Department of Infectious Disease & Vaccine Delivery, Bill and Melinda Gates Foundation, New Delhi, India., Chantler T; Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, UK., Mogasale V; Graduate School of Public Health, Yonsei University, Seoul, Republic of Korea (Current affiliation: Health Financing and Economics Department, World Health Organisation, Geneva, Switzerland)., Gopal Dhoubhadel B; School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan.; Department of Clinical Medicine and Research, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan., John Edmunds W; Department of Infectious Disease Epidemiology and Dynamics, London School of Hygiene & Tropical Medicine, London, UK.; School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan.; Department of Infectious Disease Epidemiology and Dynamics, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan., Clark A; Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK., Abbas K; Department of Infectious Disease Epidemiology and Dynamics, London School of Hygiene & Tropical Medicine, London, UK.; School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan.; Department of Infectious Disease Epidemiology and Dynamics, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.; Public Health Foundation of India, New Delhi, India.
Publikováno v:
Vaccine: X [Vaccine X] 2024 Oct 01; Vol. 21, pp. 100568. Date of Electronic Publication: 2024 Oct 01 (Print Publication: 2024).
Autor:
Mogasale V; Policy and Economic Research, International Vaccine Institute, Gwanak-gu, Korea vmogasale@ivi.int., Ngogoyo SM; Department of Health, County government of Nyandarua, Ol Kalou, Kenya., Mogasale VV; Department of Pediatrics, Yenepoya Medical College Hospital, Mangalore, India.
Publikováno v:
BMJ open [BMJ Open] 2021 Mar 23; Vol. 11 (3), pp. e044615. Date of Electronic Publication: 2021 Mar 23.
Autor:
Mogasale VV; Department of Paediatrics, Yenepoya Medical College, Mangalore, India., Saldanha P; Department of Paediatrics, Yenepoya Medical College, Mangalore, India., Pai V; Department of Microbiology, Yenepoya Medical College, Mangalore, India., Rekha PD; Yenepoya Research Centre, Yenepoya (Deemed to be) University, Mangalore, India., Mogasale V; Policy and Economic Research Department, International Vaccine Institute, Seoul, South Korea. vmogasale@ivi.int.
Publikováno v:
Scientific reports [Sci Rep] 2021 Mar 04; Vol. 11 (1), pp. 5116. Date of Electronic Publication: 2021 Mar 04.
Autor:
Mogasale V; International Vaccine Institute, Policy and Economic Research Department, Public Health, Access and Vaccine Epidemiology Unit, Seoul, South Korea. Electronic address: vmogasale@ivi.int., Mogasale VV; Department of Pediatrics, Yenepoya Medical College and Research Center, Mangalore, India., Hsiao A; Technische Universität Berlin, Department of Health Care Management, Berlin, Germany.
Publikováno v:
Vaccine [Vaccine] 2020 Feb 29; Vol. 38 Suppl 1, pp. A160-A166. Date of Electronic Publication: 2019 Oct 11.
Autor:
Saluja T; International Vaccine Institute, SNU Research Park, Seoul, Republic of Korea., Mogasale VV; Department of Pediatrics, Yenepoya Medical College and Research Center, Yenepoya University, Mangalore, India., Excler JL; International Vaccine Institute, SNU Research Park, Seoul, Republic of Korea., Kim JH; International Vaccine Institute, SNU Research Park, Seoul, Republic of Korea., Mogasale V; International Vaccine Institute, SNU Research Park, Seoul, Republic of Korea.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2020; Vol. 16 (1), pp. 42-50. Date of Electronic Publication: 2019 Sep 20.
Autor:
Mogasale VV; Epidemiology Unit, International Vaccine Institute, Seoul, Republic of Korea., Ramani E; Policy and Economic Research Department, International Vaccine Institute, Seoul, Republic of Korea., Mogasale V; Policy and Economic Research Department, International Vaccine Institute, Seoul, Republic of Korea., Park JY; Biostatistics and Data Management Department, International Vaccine Institute, Seoul, Republic of Korea., Wierzba TF; Development and Delivery Unit, International Vaccine Institute, Seoul, Republic of Korea.; PATH, 455 Massachusetts Avenue NW, Suite 1000, Washington, DC, USA.
Publikováno v:
Journal of environmental and public health [J Environ Public Health] 2018 Jul 04; Vol. 2018, pp. 9589208. Date of Electronic Publication: 2018 Jul 04 (Print Publication: 2018).
Autor:
Kar SK; Director (Research) Medical and Life Sciences, Directorate of Medical Research, IMS and SUM Hospital, Siksha 'O' Anusandhan University, Bhubaneswar, Odisha, India., Dwibedi B; Additional Professor, Department of Peadiatrics, AIIMS Bhubaneshwar, Bhubaneswar, Odisha, India., Mogasale VV; Formerly Associate Research Scientist, Departments of Epidemiology, International Vaccine Institute, Seoul, South Korea; Assistant Professor, Department of Peadiatrics, Srinivas Institute of Medical Sciences and Research Centre, Mangalore, India., Sabat J; Research Scientist, Regional Medical Research Center, Bhubaneswar, Odisha, India., Mogasale V; Head, Policy and Economic Research Department, Development and Delivery, International Vaccine Institute, Seoul, South Korea., Wierzba TF; Deputy Director General, Development and Delivery, International Vaccine Institute, Seoul, South Korea.
Publikováno v:
Indian journal of public health [Indian J Public Health] 2018 Jul-Sep; Vol. 62 (3), pp. 231-234.
Autor:
Lee JS; International Vaccine Institute, SNU Research Park, 1 Gwanak-ro, Gwanack-gu, Seoul, South Korea. jslee@ivi.int., Mogasale VV; International Vaccine Institute, SNU Research Park, 1 Gwanak-ro, Gwanack-gu, Seoul, South Korea., Mogasale V; International Vaccine Institute, SNU Research Park, 1 Gwanak-ro, Gwanack-gu, Seoul, South Korea., Lee K; International Vaccine Institute, SNU Research Park, 1 Gwanak-ro, Gwanack-gu, Seoul, South Korea.
Publikováno v:
BMC infectious diseases [BMC Infect Dis] 2016 Dec 05; Vol. 16 (1), pp. 732. Date of Electronic Publication: 2016 Dec 05.
Autor:
Mogasale V; Policy and Economic Research Department, Development and Delivery Unit, International Vaccine Institute, Seoul, Republic of Korea. vmogasale@IVI.INT., Ramani E; Policy and Economic Research Department, Development and Delivery Unit, International Vaccine Institute, Seoul, Republic of Korea., Mogasale VV; Epidemiology Department, Development and Delivery Unit, International Vaccine Institute, Seoul, Republic of Korea., Park J; Biostatistics and Data Management Department, Development and Delivery Unit, International Vaccine Institute, Seoul, Republic of Korea.
Publikováno v:
Annals of clinical microbiology and antimicrobials [Ann Clin Microbiol Antimicrob] 2016 May 17; Vol. 15 (1), pp. 32. Date of Electronic Publication: 2016 May 17.
Autor:
Mogasale V; Policy and Economic Research Department, International Vaccine Institute, SNU Research Park, 1 Gwanak-ro, Gwanak-gu, Seoul, 151-742, South Korea. vmogasale@ivi.int., Mogasale VV; Epidemiology Department, International Vaccine Institute, Seoul, South Korea. vijivittalmogasale@gmail.com., Ramani E; Policy and Economic Research Department, International Vaccine Institute, SNU Research Park, 1 Gwanak-ro, Gwanak-gu, Seoul, 151-742, South Korea. Enusa.Ramani@IVI.INT., Lee JS; Policy and Economic Research Department, International Vaccine Institute, SNU Research Park, 1 Gwanak-ro, Gwanak-gu, Seoul, 151-742, South Korea. jslee@ivi.int., Park JY; Biostatistics and Data Management Department, International Vaccine Institute, Seoul, South Korea. JuYeon.Park@IVI.INT., Lee KS; Biostatistics and Data Management Department, International Vaccine Institute, Seoul, South Korea. KangSungLee@IVI.INT., Wierzba TF; Development and Delivery Unit, International Vaccine Institute, Seoul, South Korea. twierzba@path.org.; PATH, 455 Massachusetts Avenue NW, Suite 1000, Washington, DC, USA. twierzba@path.org.
Publikováno v:
BMC infectious diseases [BMC Infect Dis] 2016 Jan 29; Vol. 16, pp. 35. Date of Electronic Publication: 2016 Jan 29.